Rocket
Premium
Excel Add-In
International
Tools
Dashboard
Screener
Spinoffs
IPOs
Register
Alerts
Sign In
Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
1-A
1-A POS
1-A-W
1-A/A
1-K
1-K/A
1-SA
1-SA/A
1-U
1-U/A
1-Z
1-Z-W
1-Z/A
1/A
10-12B
10-12B/A
10-12G
10-12G/A
10-D
10-D/A
10-K
10-K/A
10-K405
10-K405/A
10-KT
10-KT/A
10-Q
10-Q/A
10-QSB
10-QSB/A
10-QT
10-QT/A
10KSB
11-K
11-K/A
11-KT
13F-HR
13F-HR/A
13F-NT
13F-NT/A
13FCONP
144
144/A
15-12B
15-12B/A
15-12G
15-12G/A
15-15D
15-15D/A
15F-12B
15F-12G
15F-12G/A
15F-15D
18-K
18-K/A
19B-4E
2-E
20-F
20-F/A
20FR12B
20FR12B/A
20FR12G/A
24F-2NT
24F-2NT/A
25
25-NSE
25-NSE/A
25/A
253G1
253G2
253G3
3
3/A
305B2
305B2/A
4
4/A
40-17F1
40-17F1/A
40-17F2
40-17F2/A
40-17G
40-17G/A
40-202A
40-202A/A
40-206A
40-24B2
40-33
40-6B
40-6B/A
40-6C
40-6C/A
40-8B25
40-8F-2/A
40-APP
40-APP/A
40-F
40-F/A
40-OIP
40-OIP/A
40FR12B
40FR12B/A
424B1
424B2
424B3
424B4
424B5
424B7
424B8
424H
424H/A
425
485APOS
485B24E
485BPOS
485BXT
486APOS
486BPOS
486BXT
487
497
497AD
497J
497K
5
5/A
6-K
6-K/A
8-A12B
8-A12B/A
8-A12G
8-A12G/A
8-K
8-K/A
8-K12B
8-K12B/A
8-K12G3
8-K12G3/A
8-K15D5
8-K15D5/A
8-M
9-M
ABS-15G
ABS-15G/A
ABS-EE
ABS-EE/A
ADV-E
ADV-H-C
ADV-H-T
ADV-NR
ANNLRPT
APP NTC
APP ORDR
APP WD
APP WD/A
ARS
ARS/A
ATS-N
ATS-N/CA
ATS-N/MA
ATS-N/UA
AW
AW WD
C
C-AR
C-AR-W
C-AR/A
C-TR
C-U
C-U-W
C-W
C/A
C/A-W
CB
CB/A
CERT
CERTARCA
CERTBATS
CERTCBO
CERTNAS
CERTNYS
CERTPAC
CFPORTAL
CFPORTAL/A
CORRESP
CT ORDER
D
D/A
DEF 14A
DEF 14C
DEF13E3
DEF13E3/A
DEFA14A
DEFA14C
DEFC14A
DEFC14A
DEFC14C
DEFM14A
DEFM14C
DEFN14A
DEFR14A
DEFR14C
DEFS14A
DEFS14C
DEL AM
DFAN14A
DFRN14A
DOS/A
DSTRBRPT
DSTRBRPT/A
EFFECT
F-1
F-1/A
F-10
F-10/A
F-10EF
F-1MEF
F-3
F-3/A
F-3ASR
F-3D
F-4
F-4/A
F-6
F-6 POS
F-6/A
F-6EF
F-7
F-8 POS
F-80
F-N
F-X
F-X/A
FOCUSN
FOCUSN/A
FWP
G-405
G-FIN/A
IRANNOTICE
MA
MA-A
MA-I
MA-I/A
MA-W
MA/A
MSD
MSD/A
N-14
N-14 8C
N-14 8C/A
N-14/A
N-14MEF
N-18F1
N-1A
N-1A/A
N-2
N-2/A
N-23C-2
N-23C3A
N-23C3B
N-2MEF
N-30B-2
N-30D
N-30D/A
N-4
N-4/A
N-54A
N-54C
N-6
N-6/A
N-6F
N-8A
N-8A/A
N-8B-2/A
N-8F
N-8F NTC
N-8F ORDR
N-8F/A
N-CEN
N-CEN/A
N-CSR
N-CSR/A
N-CSRS
N-CSRS/A
N-MFP2
N-MFP2/A
N-PX
N-PX/A
N-Q
N-Q/A
NO ACT
NPORT-P
NPORT-P/A
NRSRO-CE
NRSRO-CE/A
NRSRO-UPD
NSAR-A
NSAR-A/A
NSAR-AT
NSAR-B
NSAR-B/A
NSAR-BT
NSAR-U
NSAR-U/A
NT 10-K
NT 10-K/A
NT 10-Q
NT 10-Q/A
NT 11-K
NT 20-F
NT 20-F/A
NT N-CEN
NT N-MFP2
NT NPORT-EX
NT-NCSR
NT-NCSR/A
NT-NSAR
NT-NSAR/A
NTFNCSR
NTN 10Q
POS 8C
POS AM
POS AMI
POS EX
POS462B
POSASR
PRE 14A
PRE 14C
PREC14A
PREC14C
PREM14A
PREM14C
PREN14A
PRER14A
PRER14C
PRRN14A
PX14A6G
QRTLYRPT
QUALIF
REG-NR
REGDEX
REGDEX/A
REVOKED
RW
RW WD
S-1
S-1/A
S-11
S-11/A
S-11MEF
S-1MEF
S-1MEF
S-3
S-3/A
S-3ASR
S-3D
S-3DPOS
S-3MEF
S-4
S-4 POS
S-4/A
S-4MEF
S-6
S-6/A
S-8
S-8 POS
S-B
S-B/A
SC 13D
SC 13D/A
SC 13E
SC 13E/A
SC 13E1
SC 13E1/A
SC 13E3
SC 13E3/A
SC 13E4
SC 13E4/A
SC 13G
SC 13G/A
SC 14D9
SC 14D9/A
SC 14F1
SC TO-C
SC TO-I
SC TO-I/A
SC TO-T
SC TO-T/A
SC14D9C
SD
SD/A
SDR/A
SE
SEC STAFF
SEC STAFF ACTION
SEC STAFF LETTER
SF-1/A
SF-3
SF-3/A
SUPPL
T-3
T-3/A
TA-1
TA-1/A
TA-2
TA-2/A
TA-W
UPLOAD
WDL-REQ
X-17A-5
X-17A-5/A
Tags
Inv. presentation
Quarterly results
Acq. announced
Bionano Genomics, Inc. (BNGO)
Create:
Alert
All
|
News
|
Filings
Date Filed
Type
Description
10/11/2023
8-K
Quarterly results
08/14/2023
8-K
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs:
"
Bionano Announces CFO Transition and Appointment of Gülsen Kama as Chief Financial Officer
"
08/09/2023
8-K
Quarterly results
Docs:
"
Bionano Reports Second Quarter 2023 Results and Highlights Recent Business Progress
"
08/04/2023
8-K
Material Modifications to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Yea...
Docs:
"
Certificate of Amendment to the Amended and Restated Certificate of Incorporation, as amended, of Bionano Genomics, Inc
",
"
Certificate of Elimination of Series A Preferred Stock
"
06/16/2023
8-K
Submission of Matters to a Vote of Security Holders Interactive Data
05/09/2023
8-K
Quarterly results
Docs:
"
Bionano Reports First Quarter 2023 Results and Highlights Recent Business Progress
"
04/24/2023
8-K
Quarterly results
04/14/2023
8-K
Quarterly results
03/13/2023
8-K
Other Events Interactive Data
03/09/2023
8-K
Quarterly results
Docs:
"
Bionano Genomics Reports Fourth Quarter and Full Year 2022 Results and Provides Revenue Outlook for 2023
"
02/03/2023
8-K
Results of Operations and Financial Condition, Other Events Interactive Data
01/05/2023
8-K
Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data
Docs:
"
Bionano Genomics Reports Preliminary Fourth Quarter and Full-Year 2022 Results - Preliminary Q4 revenue expected to be between $8.1 and $8.4 million; 29% to 33% increase over Q4 2021
"
11/30/2022
8-K
Quarterly results
11/29/2022
8-K
Quarterly results
11/28/2022
8-K
Quarterly results
11/18/2022
8-K
Quarterly results
11/03/2022
8-K
Quarterly results
08/04/2022
8-K
Quarterly results
06/10/2022
8-K
Quarterly results
05/05/2022
8-K
Quarterly results
03/01/2022
8-K
Quarterly results
Docs:
"
Bionano Genomics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Revenue Outlook for 2022
"
02/23/2022
8-K
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
01/12/2022
8-K
Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data
Docs:
"
Bionano Genomics Reports Preliminary Fourth Quarter and Full-Year 2021 Results
"
12/30/2021
8-K
Entry into a Material Definitive Agreement Interactive Data
12/23/2021
8-K
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
11/04/2021
8-K
Quarterly results
Docs:
"
Bionano Genomics Reports Third Quarter 2021 Financial Results and Highlights Recent Business Progress
",
"
Q3 Webcast and Call November 4, 2021 2 Legal Disclaimer This
"
10/19/2021
8-K
Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits Interactive Data
Docs:
"
Capitalization, Etc. 24 2.6 Financial Statements 26 2.7 Absence of Certain Changes 27 2.8 Title to and Condition of Assets 27 2.9 Real Property; Leasehold 27 2.10 Intellectual Property 28 2.11 Regulatory Matters 33 2.12 Material Contracts 36 2.13 Liabilities 38 2.14 Compliance with Laws; Export Controls 38 2.15 Certain Business Practices 39 2.16 Tax Matters 40 2.17 Employee Benefit Plans and Employee Matters 42 2.18 Environmental Matters 46 2.19 Insurance 46 2.20 Legal Proceedings; Orders 47 2.21 Non-Contravention; Consents 47 2.22 Financial Advisor 47 2.23 Related Party Transactions 47 2.24 [Reserved] 47 2.25 Customers and Suppliers 47 2.26 Takeover Statutes 48 2.27 Bank Accounts, Books and Records 48 2.28 HSR Act 48 2.29 Warranty Matters 48 2.30 Accounts Receivable 49 2.31 Reliance 49 SE...
"
10/12/2021
8-K
Acquisition/merger/asset purchase announced
Docs:
"
Bionano Genomics, Inc. 2020 Inducement Plan dated August 20, 2020, as amended
",
"
Bionano Genomics to Acquire BioDiscovery, Furthering Bionano’s Vision of Creating the Most Comprehensive Variant Analysis Platform in Genomics
",
"
Investor Presentation
"
08/04/2021
8-K
Quarterly results
Docs:
"
Bionano Genomics Reports Second Quarter 2021 Financial Results and Highlights Recent Business Progress
",
"
ADDED EXPERIENCED TALENT TO MANAGEMENT TEAM NEW GLOBAL REGIONS
"
06/11/2021
8-K
Quarterly results
05/14/2021
8-K
Quarterly results
05/13/2021
8-K
Quarterly results
03/24/2021
8-K
Quarterly results
03/23/2021
8-K
Quarterly results
Next >>
Rocket Data Systems, Inc. © 2019 |
Contact Us
|
Data Disclaimer
|
Terms of Use
|
Privacy